Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients - Test2 - elhamkhani - TriplyDB

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

http://www.wikidata.org/entity/Q24187213

about

Exposure to Mycophenolate and Fatherhood.Hepatitis B in renal transplant patients.Renal association clinical practice guideline in post-operative care in the kidney transplant recipient Comparative metabolism of mycophenolic acid by glucuronic acid and glucose conjugation in human, dog, and cat liver microsomes.Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East Asians.

P2860

Q30491234-0E65A418-6D4A-400E-AB71-2936F548F504 Q41690591-60B5EAB8-7FA2-4B0B-8B5D-1AEEDD61D730 Q42343473-8C8B955A-6F7B-44D3-98D8-68FE45E610F9 Q46532736-3BAE22D8-ECA5-4689-8D7A-E7F54D1308D4 Q47114058-D50BEA02-BEAC-4023-B415-06A962A72F5C

P2860

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

http://www.wikidata.org/entity/Q24187213

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Mycophenolic acid versus azath ...... r kidney transplant recipients

@ast

Mycophenolic acid versus azath ...... r kidney transplant recipients

@en

Mycophenolic acid versus azath ...... r kidney transplant recipients

@en-gb

Mycophenolic acid versus azath ...... r kidney transplant recipients

@nl

type

label

Mycophenolic acid versus azath ...... r kidney transplant recipients

@ast

Mycophenolic acid versus azath ...... r kidney transplant recipients

@en

Mycophenolic acid versus azath ...... r kidney transplant recipients

@en-gb

Mycophenolic acid versus azath ...... r kidney transplant recipients

@nl

prefLabel

Mycophenolic acid versus azath ...... r kidney transplant recipients

@ast

Mycophenolic acid versus azath ...... r kidney transplant recipients

@en

Mycophenolic acid versus azath ...... r kidney transplant recipients

@en-gb

Mycophenolic acid versus azath ...... r kidney transplant recipients

@nl

P1433

Q24187213-AEF21E37-23EA-45B6-8B1D-08E9ABA67BF7

P1476

Q24187213-29F6BD1E-D485-4D6A-8847-6A02CBA46849

P2093

Q24187213-5C98709E-FA20-45FC-8C57-E2C2DD3BA91E

Q24187213-69329C12-46C8-4FC7-A23B-1887192A0988

Q24187213-83E00DE2-A219-48B2-8956-6D2384FB307E

Q24187213-FAB29C5F-86CB-4DBB-81D6-675567D0366A

P2860

Q24187213-009F58ED-5A50-4B9D-952C-595240D41246

Q24187213-0467A16F-5E70-4FAD-B69F-8B78CFD9FA0B

Q24187213-04722128-6A10-43C3-A61E-068C6196AD20

Q24187213-054F0C31-04FF-4965-A3CB-D0F86A5E8056

Q24187213-12068BFF-78E8-41EF-BA06-01B16357E0FF

Q24187213-164570FB-1EBC-4CCD-A17D-00411DE93EE6

Q24187213-17F0B097-8ECD-427B-B988-64A62E91A3D4

Q24187213-18EC3612-5F5C-48CD-8625-DE17578FA9E7

Q24187213-1B19A834-DFAD-4677-9639-CA5F9E0F1F1A

Q24187213-1BFA7DFD-52FF-45D7-A80A-587E608CF5B9

P31

Q24187213-3907F481-B0D9-420C-9210-EC0E382841E2

Q24187213-fb517761-d549-4172-956d-65ad0edf3062

P356

Q24187213-1D6F20B9-9DD7-403D-A515-5D0F779EF6B5

P50

Q24187213-194F3071-85BE-489D-9789-3169FA3F102B

Q24187213-5C8D1311-4303-4167-BA34-43198E5BE78E

P577

Q24187213-A0C0B79E-A446-46E2-B329-7592402AAE5C

P698

Q24187213-9F0DB198-D47F-4CD2-AEE9-98169BB7713D

P921

Q24187213-06A51A6A-1B4F-408E-99AF-04FFB7E569A0

P356

14651858.CD007746.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Mycophenolic acid versus azath ...... r kidney transplant recipients

@en

P2093

Amy K Earley

http://www.w3.org/2001/XMLSchema#string

Ethan M Balk

http://www.w3.org/2001/XMLSchema#string

Katrin Uhlig

http://www.w3.org/2001/XMLSchema#string

Martin Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

Grading quality of evidence and strength of recommendations

The case of the misleading funnel plot

Measuring inconsistency in meta-analyses

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

P31

scholarly article

P356

10.1002/14651858.CD007746.PUB2

http://www.w3.org/2001/XMLSchema#string

P50

Angela Claire Webster

Christopher H. Schmid

P577

2015-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26633102

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression